Unconfigured Ad

Collapse

Discussion of next-gen sequencing related bioinformatics: resources, algorithms, open source efforts, etc

Forums Topics Posts Last Post
No forums found.
  •  
  • Time
  • Answered
  • Show
  • New Topics
Clear All
new posts
There are no conversations in this channel.
 
  • Time
  • Show
Clear All
new posts
Please log in to your account to view your subscribed posts.
  •  
  • Time
  • Answered
  • Show
  • Sort By
  • Order
Clear All
new posts
Topics Statistics Last Post
Started by laura, 05-09-2011, 04:42 AM
35 responses
108,024 views
0 reactions
Last Post laura
by laura
 
Started by sci_guy, 01-23-2008, 11:19 PM
236 responses
688,211 views
1 reaction
Last Post ECO
by ECO
 
Started by floydian_slip, 08-13-2020, 06:42 AM
0 responses
1,365 views
0 reactions
Last Post floydian_slip  
Started by seqlt, 08-06-2020, 11:39 AM
2 responses
4,850 views
0 reactions
Last Post seqlt
by seqlt
 
Started by Matt.Kanke, 08-11-2020, 04:38 PM
0 responses
1,825 views
0 reactions
Last Post Matt.Kanke  
Started by geeneticode, 08-07-2020, 07:57 AM
2 responses
3,889 views
0 reactions
Last Post geeneticode  
Started by gugpuccio, 08-06-2020, 06:10 AM
0 responses
1,539 views
0 reactions
Last Post Eira
by Eira
 
Started by ecSeq Bioinformatics, 08-05-2020, 11:27 PM
0 responses
2,319 views
0 reactions
Last Post ecSeq Bioinformatics  
Started by AlexSTorson, 08-04-2020, 09:18 AM
0 responses
3,103 views
0 reactions
Last Post AlexSTorson  
Started by yueli, 08-04-2019, 10:40 AM
5 responses
2,620 views
0 reactions
Last Post arjeet45o  
Started by ETHANol, 11-04-2011, 04:12 AM
21 responses
13,222 views
0 reactions
Last Post pi270
by pi270
 
Started by Simoner, 10-11-2019, 05:58 AM
4 responses
5,765 views
0 reactions
Last Post Simoner
by Simoner
 
No topics found.
  • Time
Clear All
No photos found.
  • Time
Clear All

Webinars

Collapse

Recent Articles

Collapse

  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM
  • SEQadmin2
    How Immunogenomics Decodes Immunity’s Genetic Blueprint
    by SEQadmin2




    The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.

    This convergence of genetics, immunology, and computation...
    09-01-2026, 05:41 AM
  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 09-29-2026, 09:51 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-25-2026, 09:06 AM
0 responses
39 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 09-23-2026, 11:05 AM
0 responses
30 views
0 reactions
Last Post SEQadmin2  
Working...